When Savings Belong to the Next Plan
A patient changing insurance plans can turn prevention into nobody’s asset. That is the uncomfortable little engine inside Russell Greenfield’s recent argument: an insurer may pay today for a program that helps prevent chronic illness, only to watch the eventual savings land with another plan after the member moves on. The person may be better off. The original payer may be out of pocket. And the spreadsheet, as usual, can make a sensible long-term decision look foolish in the short run.
Greenfield, founding executive director of The Institute for the Advancement of Whole Health at Southern California University of Health Sciences, is not arguing that affordability no longer matters. Quite the opposite. His point is that cost debates get thin fast when they ignore what spending actually accomplishes for patients. Paying less for care that fails people is not much of a victory. Paying more without asking whether health improves is no prize either.
“We have spent decades debating how to pay for healthcare. It's time to give equal attention to how we invest in health,” Greenfield writes.
That distinction deserves more attention than it gets. Healthcare has plenty of machinery for processing a visit, a test, or a procedure. Prevention can be messier. Its benefits may show up years later, may depend on circumstances beyond a clinician’s office, and may not fit neatly inside the coverage rules of one health plan. Nobody loves funding a benefit when another party could eventually harvest the financial upside. Yet that is precisely the kind of handoff the system has to confront.
Payment Reform Has Not Solved the Ownership Problem
Greenfield acknowledges that payment reform has moved the ball by rewarding better outcomes rather than simply more services. Fair enough. Volume-for-volume payment has long had obvious blind spots. But an outcomes label does not automatically settle who pays for prevention, when they pay, or how broadly the relevant outcome should be defined. If the crucial opportunity sits outside what a plan traditionally covers, the incentives can still get awfully warped.
Employers, insurers, healthcare organizations, and community institutions all enter Greenfield’s question because none of them controls the whole chain. Employers may care about workforce health, but workers change jobs. Insurers face enrollment churn. Healthcare organizations operate within payment arrangements that may not reward every preventive effort. Community institutions can influence the conditions around health yet may not have deep pockets or a direct claim on later savings. This is less a single-bad-guy story than a coordination problem with real financial consequences.
Investors Should Watch the Incentive Plumbing
From a sector-watch perspective, the useful question is not whether prevention is morally appealing. It plainly can be. The harder question is whether the payment architecture gives decision-makers a reason to fund it consistently. Investors watching healthcare businesses should pay attention to where financial responsibility and long-term benefit separate. That gap can shape product design, employer offerings, partnerships, and the willingness of organizations to try approaches whose payoff may arrive after a patient, employee, or member has departed.
There is no promised fix in Greenfield’s article, and pretending otherwise would be cheap talk. The source material raises questions rather than declaring a universal blueprint: how should costs be shared, and what happens when the eventual return goes to somebody else? Those are serious questions because the answers could require cooperation among institutions that are accustomed to guarding their own budgets. Cooperation sounds lovely right up until someone has to sign the check.
Health Is Bigger Than a Covered Service
SCU, founded in 1911, frames its educational mission around integrative, whole-person health across a broad range of programs. That backdrop helps explain why Greenfield presses beyond the usual payer-provider discussion. His argument is not merely about refining billing codes. It asks whether the boundaries of covered healthcare are too narrow for some of the most consequential opportunities to improve health.
That does not make every prevention proposal automatically effective, affordable, or appropriate. It does mean the current accounting deserves a harder look. A system that can identify future savings but refuses to invest because someone else might receive them is behaving rationally at the individual-organization level and irrationally at the broader level. That contradiction has been sitting in plain sight for a long time.
The Debate Worth Having
Greenfield’s contribution is a clean reframing: affordability should include value delivered to patients, not merely the immediate price tag. The next step is tougher, slower, and decidedly unglamorous—figuring out how institutions share risk and credit when health gains take time. Still, that is the work. Until the incentives stop punishing the party that acts early, prevention will keep getting applause in speeches and hesitation in budgets.